Cargando…

Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics

Non-alcoholic fatty liver disease (NAFLD) is a leading cause of liver cirrhosis and hepatocellular carcinoma. NAFLD is associated with metabolic disorders such as obesity, insulin resistance, dyslipidemia, steatohepatitis, and liver fibrosis. Liver-resident (Kupffer cells) and recruited macrophages...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagashimada, Mayumi, Honda, Masao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348401/ https://www.ncbi.nlm.nih.gov/pubmed/34360773 http://dx.doi.org/10.3390/ijms22158008

Ejemplares similares

Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis
por: Ni, Yinhua, et al.
Publicado: (2016)

Probiotics and Prebiotics as a Strategy for Non-Alcoholic Fatty Liver Disease, a Narrative Review
por: Castillo, Valentina, et al.
Publicado: (2021)

Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
por: Mijangos-Trejo, Alejandra, et al.
Publicado: (2023)

Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
por: Kanchanasurakit, Sukrit, et al.
Publicado: (2022)

The Gastrointestinal Microbiome and Musculoskeletal Diseases: A Beneficial Role for Probiotics and Prebiotics
por: Vitetta, Luis, et al.
Publicado: (2013)

Effects of Probiotic and Prebiotic Supplementation on Leptin, Adiponectin, and Glycemic Parameters in Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial
por: Behrouz, Vahideh, et al.
Publicado: (2017)

The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials
por: Xing, Wenmin, et al.
Publicado: (2022)

Probiotics, prebiotics, and the host microbiome: the science of translation
por: Petschow, Bryon, et al.
Publicado: (2013)

The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review
por: Carpi, Rodrigo Zamignan, et al.
Publicado: (2022)

The role of the gut microbiome and exercise in non-alcoholic fatty liver disease
por: Houttu, Veera, et al.
Publicado: (2020)

Probiotics, prebiotics and their role in Alzheimer’s disease
por: D'Argenio, Valeria, et al.
Publicado: (2021)

Protective effect of probiotics in patients with non-alcoholic fatty liver disease
por: Cai, Gen-shen, et al.
Publicado: (2020)

Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
por: Xie, Chencheng, et al.
Publicado: (2019)

The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
por: Jennison, Erica, et al.
Publicado: (2021)

The Microbiome and Alzheimer’s Disease: Potential and Limitations of Prebiotic, Synbiotic, and Probiotic Formulations
por: Arora, Karan, et al.
Publicado: (2020)

The microbiome in non-alcoholic fatty liver disease: associations and implications
por: Lin, Eugenia A., et al.
Publicado: (2014)

The Gut Microbiome in Schizophrenia and the Potential Benefits of Prebiotic and Probiotic Treatment
por: Liu, Jonathan C. W., et al.
Publicado: (2021)

Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
por: Gupta, Haripriya, et al.
Publicado: (2022)

Probiotics, prebiotics and amelioration of diseases
por: Tsai, Yu-Ling, et al.
Publicado: (2019)

Probiotics and Prebiotics in Cardiovascular Diseases
por: Romero, Miguel, et al.
Publicado: (2023)

The Influence of the Gut Microbiome on Obesity in Adults and the Role of Probiotics, Prebiotics, and Synbiotics for Weight Loss
por: Aoun, Antoine, et al.
Publicado: (2020)

Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular Diseases
por: Oniszczuk, Anna, et al.
Publicado: (2021)

The Role of Prebiotics and Probiotics in Prevention of Allergic Diseases in Infants
por: Sestito, Simona, et al.
Publicado: (2020)

Probiotics and Prebiotics: Any Role in Menopause-Related Diseases?
por: Barrea, Luigi, et al.
Publicado: (2023)

Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease
por: Yamada, Kazutoshi, et al.
Publicado: (2018)

Effects of probiotics on non-alcoholic fatty liver disease: a review of human clinical trials
por: Cao, Chujin, et al.
Publicado: (2023)

The clinical effect of probiotics on patients with non-alcoholic fatty liver disease: a meta-analysis
por: Wang, Yuxue, et al.
Publicado: (2023)

What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics?
por: van Dorst, Josie M., et al.
Publicado: (2022)

Handbook of probiotics and prebiotics /
Publicado: (2009)

Dysbiosis, Probiotics, and Prebiotics: In Diseases and Health
por: Appanna, Vasu D.
Publicado: (2018)

Probiotics, prebiotics, and postbiotics in health and disease
por: Ji, Jing, et al.
Publicado: (2023)

Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol
por: Lambert, Jennifer E., et al.
Publicado: (2015)

The Role of Probiotics and Prebiotics in Inducing Gut Immunity
por: Vieira, Angélica T., et al.
Publicado: (2013)

The role of probiotics, prebiotics and synbiotics in animal nutrition
por: Markowiak, Paulina, et al.
Publicado: (2018)

The Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesity
por: Cerdó, Tomás, et al.
Publicado: (2019)

Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease
por: Saltzman, Emma T., et al.
Publicado: (2018)

Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Honda, Yasushi, et al.
Publicado: (2020)

More on Current Evidences on Probiotics as a Novel Treatment for Non-Alcoholic Fatty Liver Disease
por: Vajro, Pietro, et al.
Publicado: (2013)

Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review
por: Sabirin, Faezah, et al.
Publicado: (2022)

Modulation of hepatic stellate cells by Mutaflor(®) probiotic in non-alcoholic fatty liver disease management
por: Hany, Noha M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_inp0g67i3aep4263mbfdenta28